Objective The popularity of contemporary microsurgical techniques in treatment of lower-limb lymphedema calls for better visualization of the lymphatic system, both preoperatively and intra-operatively. The aim of this prospective study was to investigate the feasibility of a novel combination of 68 Ga-NEB positron emission tomography (PET) with magnetic resonance lymphography (MRL) in evaluating lymphedema and guiding surgical intervention. Methods A total of 11 patients (F 9, M 2, age range 29-69 y) with lower-limb lymphedema classified into stage I to III were recruited. PET acquisition was performed at 30, 60 and 90 min after subcutaneous injection of the albumin-binding radiotracer 68 Ga-NEB into the bilateral first web spaces of the feet. All the patients were also subjected to 99m Tc-sulfur colloid (SC) lymphoscintigraphy for comparison. Gd-DTPA-enhanced magnetic resonance imaging (MRI) was performed using sequences specialized for lymphatic vessel scans. All the patients underwent surgical interventions within a week. The surgical approach includes the use of a linear marker for edema localization and indocyanine green (ICG) lymphography with a near-infrared surgical navigation system intraoperatively. Results Lymph transport in lymphatic channels was clearly observed by visualization of 68 Ga-NEB activity in the lymphatic vessels and within lymph nodes for all 11 patients as well as the visualization of the edema section plane with dermal backflow (DB), abnormally increased and disconnected uptake along the lymphatic channels. Preoperative 68 Ga-NEB PET combined with MRL provides advantageous threedimensional images, higher temporal resolution, significantly shorter time lapse before image acquisition after tracer injection and more accurate pathological lymphatic vessel distribution than Tc-SC lymphoscintigraphy/MRL in the evaluation of lymphedema severity, staging and pathological location of lymph vessels to make an individualized treatment plan. Dual 68 Ga-NEB PET/MRL is thus recommended before the operation for staging and therapy planning.
Ga-NEB into the bilateral first web spaces of the feet. All the patients were also subjected to 99m Tc-sulfur colloid (SC) lymphoscintigraphy for comparison. Gd-DTPA-enhanced magnetic resonance imaging (MRI) was performed using sequences specialized for lymphatic vessel scans. All the patients underwent surgical interventions within a week. The surgical approach includes the use of a linear marker for edema localization and indocyanine green (ICG) lymphography with a near-infrared surgical navigation system intraoperatively. Results Lymph transport in lymphatic channels was clearly observed by visualization of 68 Ga-NEB activity in the lymphatic vessels and within lymph nodes for all 11 patients as well as the visualization of the edema section plane with dermal backflow (DB), abnormally increased and disconnected uptake along the lymphatic channels. Preoperative 68 Ga-NEB PET combined with MRL provides advantageous threedimensional images, higher temporal resolution, significantly shorter time lapse before image acquisition after tracer injection and more accurate pathological lymphatic vessel distribution than Tc-SC lymphoscintigraphy/MRL in the evaluation of lymphedema severity, staging and pathological location of lymph vessels to make an individualized treatment plan. Dual Introduction Lower-limb lymphedema has become an important medical issue due to its high frequency of occurrence and compromised quality of life, especially in patients who have undergone intrapelvic or intra-abdominal cancer surgery or radiation treatment [1] . Although conservative nonsurgical treatment has been the dominant therapy for lymphedema, contemporary microsurgical techniques became more popular due to the minor invasiveness and being effective in reducing excess limb volume, the risk of cellulitis, and the need for compression garment use and lymphedema therapy [2] [3] [4] . For example, lymphaticovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT) lymphaticolymphatic bypass can treat the excess fluid component of lymphedema swelling that presents as pitting edema [5] . Suction-assisted protein lipectomy (SAPL) is a minimally invasive procedure that addresses the solid component of lymphedema swelling that typically occurs later in the disease process and presents as chronic non-pitting lymphedema [6] (Table 1) Visualization of the lymphatic system is necessary for identifying and monitoring lymphedema, which is also critical to optimize surgery outcome. However, the localization of the responsible lymph vessels related to lymphedema remains a challenge and a time-consuming difficult procedure [7] due to visibility limitations arising from the diameter of lymph vessels (0.4-0.8 mm) which contain few cells with mainly clear lymph fluid, long-term chronic fibrosis and inflammatory stimulations [8] . To overcome the challenge, various imaging modalities have been applied to assess lymphatic vessels, such as optical imaging by injecting a fluorescent indocyanine green (ICG) dye to provide intra-operative guidance [8] [9] [10] [11] , magnetic resonance lymphography (MRL) [12] and radionuclide lymphoscintigraphy for preoperative evaluation [11, [13] [14] [15] .
For preoperative imaging, the commonly used lymphoscintigraphy method utilizes a scintillation camera to produce repeating two-dimensional (2D) images with lymphatic drainage. However, this technique does not allow clear location of lymphatic vessels due to the poor resolution. Besides, 99m Tc-labeled sulfur colloid (SC) are relatively large particles that do not effectively migrate in extremities of patients with lymphedema, resulting in a relatively long waiting time before and during scanning. Our previous studies have reported positron emission tomography (PET) lymphangiography with 68 Ga-labeled NOTA (1,4,7-triazacyclononane-N,N',N^-triacetic acid) conjugated with truncated Evans blue (NEB), which forms a complex with serum albumin in the interstitial fluid after local injection and allows for rapid visualization of the lymphatic system [16, 17] . Clinical investigations also showed effectiveness of NEB PET in assessing the lymph system [18, 19] . On the other hand, MRL has the advantage of higher resolution than gamma scintigraphy or single-photon emission computed tomography (SPECT) lymphoscintigraphy [20, 21] . MRL with contrast enhancement has been used for examining extremity lymphedema, because it can accurately evaluate the anatomical status of lymphatic vessels and lymph nodes in lymphedema [22] .
The aim of this prospective study is to evaluate the feasibility of combination of 68 Ga-NEB PET lymphangiography with MRL and ICG optical imaging in lymphedema staging and guiding therapy for patients with lower-limb lymphedema.
Materials and methods

Patient recruitment
Patients were recruited from the Therapy Center of Lymphedema Disease in China, Department of Plastic Surgery, Peking Union Medical College Hospital. This clinical study was approved by Enrolled patients were 18 years and older, in suspicion of lymphedema of the lower limb, with a history of lymph node dissection and radiotherapy in the groin area. Exclusion criteria consisted of conditions of mental illness, severe liver or kidney disease with serum creatinine > 3.0 mg/dl (270 μM) or any hepatic enzyme level 5 times or more than normal upper limit. Participants were also excluded if they were known to have severe allergy or hypersensitivity to intravenous (IV) radiographic contrast, claustrophobia to accept PET or magnetic resonance imaging (MRI) scanning, or female patients in pregnancy or breast feeding.
Clinical staging
According to Common Terminology Criteria for Adverse Events v4.0 (CTCAE), staging was based on the severity of the edema limb from foot to groin, degree of skin keratosis or fibrosis (signs and symptoms) [23] . No patient was at stage 0 (or Ia), which refers to a latent or subclinical condition where swelling is not yet evident despite impaired lymph transport, subtle changes in tissue fluid/composition, and changes in subjective symptoms. Three patients were diagnosed as stage I, in which pitting edema was found with early accumulation of fluid relatively high in protein content, and subsided with limb elevation. Four patients were diagnosed as stage II. In these patients, facultative pitting edema was manifest, and limb elevation rarely reduced tissue swelling. Four patients were diagnosed as stage III without pitting, fat deposits, skin hyperkeratosis, warty overgrowth and elephantiasis. Tc-SC into the first and second interdigital spaces of both feet (0.5 mL, 37 MBq/per foot) with a double-head gamma camera with a lowenergy high-resolution parallel hole collimator in whole-body scanning mode at a speed of 10 cm/min. More spots and whole body images were obtained for up to 24 h. 
Imaging protocols
Ga-NEB PET
Preparation of NEB and
68 Ga labeling were performed as described in our previous publications [18, 19] . After subcutaneous injection of 68 Ga-NEB into the bilateral first web spaces of the feet (0.5 mL, 37 MBq/foot), patients were requested to walk. Thirty minutes later, PET scans were performed from the foot to the cervical area including the thoracic duct (7-9 bed positions, 2 min/bed) after low-dose CT scanning (140 kV, 35 mA, pitch of 1:1, 5-mm thickness with 3-mm gap, 512 × 512 matrix, 70-cm field of view) for localization purpose. At 60 and 90 min, PET scans were also performed (5-7 bed positions, 2 min/bed) for each patient, covering from the foot ankle to the pubic symphysis (Fig. 1) .
MRL
MRL was performed with a 3.0-T MR unit (GE Discovery MR 750 3.0T) the day after PET imaging. Unenhanced T 1 and heavily T 2 -weighted MRI scans were acquired first and then the contrast agent Gd-DTPA was injected subcutaneously into the bilateral web spaces of the feet (0.6-0.8 mL per injection site). 3D contrast-enhanced MRI images were acquired 2 min later using sequences specialized for lymphatic vessel scans with a slice thickness of 2 mm and a total scan time of 40-50 min (Fig. 1 ).
Indocyanine green (ICG) lymphangiography
All the patients underwent surgical interventions within 1 week after admission, and have all agreed to receive indocyanine green (ICG) lymphography. 0.1 mL of ICG (2.5 mg/mL) was injected subdermally between the toes with a 1-mL syringe and a 24-G needle, followed by a foot massage for 5 min from the distal to proximal end of the foot. The fluorescence imaging system was developed by the Key Laboratory of Molecular Imaging of Chinese Academy of Sciences [24, 25] (Fig. 1) .
Image analysis
Visual methods were applied for image analysis. Additional comparative reviews were performed between 68 Ga-NEB PET, MRL and 99m Tc-SC lymphoscintigraphy. The images were analyzed together by two experienced nuclear medicine physicians, and two experienced radiologists together. The criteria of the visual analysis were as followings: (1) Lymphatic vessel visualization of lower extremities (yes/no); (2) The affected lymph vessels line shape; (3) When probe transport/contrast agent transport is identified on PET/MR lymphangiography in each level; (4) Signal intensity on PET/MRL; (5) Dermal backflow (DB) appearance (yes/no); (6) DB area and degree; (7) DB pattern; (8) Thickening and dilated dermal lymphatics (yes/no); (9) Honeycomb pattern (yes/no); (10) Lymph node accumulation defect degree (high/moderate/low intensity/non-uptake of the PET imaging agent); (11) All imaging analysis criteria above were also based on bilateral comparative analysis; (12) ICG optical imaging (linear/splash/stardust/diffuse).
Imaging-guided surgery
Surgical plans were made based on the preoperative imaging information regarding both the function and location of lymph vessels provided by 
Results
Patient demographics
From August 2015 to September 2016, a total of 11 patients [F 9, M 2, age range 29-69 y (49.8 ± 12.4); weight range 51.0-71.0 kg (64.2 ± 7.28)] with different levels of lower-limb lymphedema were recruited. These patients had been Ga-NEB to a patient with lymphedema. d A representative contrast-enhanced 3D MR image of lymphatic vessels after subcutaneous injection of Gd-DTPA. e Structure of ICG. f Real-time ICG lymphography acquired intra-operatively. g The fluorescence camera used for ICG imaging diagnosed for 1.5-5 years. The diagnosis of lower-extremity lymphedema was made by patient's medical history, physical examination and indirect radionuclide lymphoscintigraphy. Cases with acute inflammation, chronic venous insufficiency and systemic etiology of edema were excluded from the study.
Preoperative 68
Ga-NEB PET and MRL
The lymphatic vessels in the normal lower limbs showed an intermittent, low signal intensity line on MRL and a high signal intensity line on 68 Ga-NEB PET. The branches could be clearly observed in both images. In contrast, the lymph ducts were viewed as obstructed, beaded, dilated, tissue swollen, and presented with irregularly high signal intensity on PET for the lymphedema-affected lower extremities. The affected lymph vessels were also visualized as beaded, dilated, and tortuously high signal intensity vessels on MRL with the contrast agent infiltrating both dermal and subcutaneous layers.
As functional imaging modalities, both 68
Ga-NEB PET and MRL showed different imaging patterns in patients with different lymphedema stages and correlated well with the development of lymphedema. Stage I lymphedema presented less visualized lymphatic vessels, while the delay of probe and contrast agent transport were identified on PET and MRL. No obvious dermal backflow appearance of the subcutis was seen at the distal abnormal lymph duct, though proximal duct or mild dermal backflow near inguinal region could happen. Lymph node accumulation defect on the affected side with low intensity of the PET tracer was identified compared to the contralateral normal limb (Fig. 2) .
Stage II lymphedema presented two types of imaging patterns. Thickening and dilated dermal lymphatics and lymph lakes with sequestered fluid shown as a Bhoneycomb pattern (  Fig. 3) were commonly seen in PET and MRL images. Late in stage II, as excess fat and fibrosis supervenes, compensatory vessels could be shown around the damaged lymph vessels with contrast agent accumulation between fat surrounded by fibrotic tissue. Lymph node accumulation defect on the affected side with low intensity to non-uptake of the PET imaging agent was found, with the LNs from the contralateral normal limb as the reference control (Fig. 3) .
In stage III lymphedema,
68
Ga-NEB PET and MRL revealed abnormal distribution of contrast agent in the subcutaneous layer as being large, irregular, patchy-shaped DB. Increased subcutaneous thickness and diffuse fibrosis were shown in MR imaging, along with locally increased uptake of the PET imaging agent. Both PET and MRL showed dilated lymph vessels and damaged lymph vessels even with severe fibrosis. Tortuous and deep-seated lymph vessels were commonly seen due to overall overgrowth of adipose tissue. Lymph node accumulation defect on the affected side without obvious uptake of the PET imaging agent was observed (Fig. 4) .
Differences between 68
Ga-NEB PET and 99m
Tc-SC lymphoscintigraphy
Compared with 99m Tc-SC lymphoscintigraphy, 68 Ga NEB PET/CT images showed better lymphatic channel visualization as early as 30 min after intra-cutaneous injection. The lymphatic channels and veins were also identified clearly in delayed imaging at either 60 or 90 min after tracer injection. In addition, 68 Ga-NEB PET lymphangiography showed dermal backflow and lymph node accumulation defect, abnormal lymphatic channels and a potential anastomosis pathway. In comparison, the images of 99m Tc-SC lymphoscintigraphy had to be acquired much later (5.5 ± 4.7 h) and repeated delayed imaging to 24 h. Tc-SC lymphoscintigraphy showed dermal backflow and lymph node accumulation defect (Figs. 2, 3 and 4).
Imaging-guided surgery
Based on PET and MRL, we have designed the proper incision sites and performed lymphatico-venous, lymphaticolymphatic anastomosis and/or liposuction for the lymphedema patients of different stages. The locations of the pathological lymphatic vessels were pinpointed based on the following standard: (i) an intermittent, linear, tubular structure with high signal intensity line on both 68 Ga-NEB PET and MRL, and with low signal intensity at the proximal end; (ii) the vessels were found right under the dermal and the length was at least 3 mm. The suitably sized lymphatic channel was prepared for an end-to-end anastomosis and the caliber size was more than 0.3 mm; (iii) no branches or tortuous part; (iv) no contrast agent filtration in surrounding areas.
With the guidance of pre-operative NEB PET and MRL and intra-operative ICG optical imaging, three patients diagnosed as stage I lymphedema received multiple lymphaticovenular anastomosis, four patients with stage II lymphedema received lymphaticovenular anastomosis and liposuction, and four patients with stage III lymphedema received liposuction only. The observations found during surgery were consistent with the findings on PET and MRL images. The surgical interventions went smoothly and no postoperative complications were observed. All patients were discharged within 5 days after surgery.
Discussion
Lymphedema is the result of an overload of lymph fluid that accumulates in the subcutaneous space, causing an increase in limb weight, a decreased limb function, an increased risk of infection, a compromised quality of life, and interference with body appearance [26, 27] . Mapping the lymph system is important in the diagnosis and treatment of lymphedema, especially for surgery interventions [28] . Through 68 Ga-NEB PET and MRL, morphologic and functional characteristics of lymphatic vessels in patients with lower-extremity lymphedema were visualized. Moreover, the imaging results correlated well with the development of lymphedema. For stage I patients, symptoms are subtle and edema is reversible, thus patients and physicians often ignore the possibility of worsening of the lymphatic system. With the disease progression, edema becomes evident, irreversible and in larger scale, but the affected lymphatic vessels have already suffered fibrosis in varying degrees due to long-time inflammation stimulation, which makes it difficult for surgeons to ameliorate this situation. For this reason, only liposuction is possible for stage III patients. Therefore, early diagnosis and treatment of lymphedema is important to improve disease prognosis.
Our study confirmed that 68 Ga-NEB PET and MRL are synergistic. PET examination could be performed with a large field of view first to locate the range of edema and make assessment of affected lymphatic vessels. MRL could further clarify the degrees of interstitial edema and fibrosis, and point out the position and depth of lymphatic vessels with anatomic accuracy. Thus, the combination of both imaging techniques does improve the sensitivity and specificity of early detection of lymphatic lesions. The early abnormal manifestations include delayed radiotracer transport, dermal infiltration and poor visualization of lymphatic collectors, which all suggest the presence of proximal lymphatic flow obstruction.
Surgical interventions for limb lymphedema including LVA and SAPL help reduce the frequency of cellulitis attack and other symptoms [29] . The crucial key to successful LVA is to find the dilated and functional lymphatic vessels to ensure the success of anastomosis [30] . However, it is difficult since the lymph ducts are often sclerotic in the late-stage lymphedema [31] . PET/MRL could provide detailed anatomic and functional delineation of the lymphatic system, including the number, caliber, location and distribution of lymphatic vessels. This information is very helpful in planning and predicting the lymphatic microsurgery.
The principles of lymphatic imaging using either 68 Ga-NEB or 99m Tc-SC are similar. After local injection, 68 Ga-NEB complexes with endogenous albumin in the interstitial fluid and allows for visualizing the lymphatic system. For the 99m Tc-SC lymphoscintigraphy, 99m Tc-labeled antimony sulfide colloid move at a rate similar to that of the physiologic flow of lymph and is sufficiently retained by intervening nodes from the interstitial injection site to the lymphatic channels and nodes. However, we found that PET examination is superior to planar whole-body 99m Tc-SC lymphoscintigraphy in lymphedema, although both imaging modalities showed dermal backflow and lymph node accumulation defect. With dynamic 3D 68 Ga-NEB PET, abnormal lymphatic channels, the location of individual lymphatic channels and a potential anastomosis pathway for LVA could be visualized for surgical planning. Continuous bed positioning facilitates large field of view coverage from the feet to cervical area including the thoracic duct, which is generally necessary to evaluate lymphatic drainage disorders. Moreover, 68 Ga NEB PET lymphangiography takes much less waiting time after contrast injection, and less scanning time for the patients compared with planar whole-body 99m Tc-SC lymphoscintigraphy which needs several hours to acquire multiple bed positions or even longer time for repeated delayed planar 99m Tc-SC lymphoscintigraphy imaging.
In clinics, the staging of lymphedema is based mainly on patient history and symptoms and still lacks imaging techniques that could provide effective information to assess possible tissue changes related to the stage of lymphedema.
68
Ga-NEB PET-MRL showed distinct imaging patterns in different stages of lymphedema, implying that imaging could be useful in staging patients for more precise therapy planning. Indeed, in stage II cases, LVA was performed in the location where the functional lymph vessels could be found in PET/MRL, while liposuction was performed in the fibrosis part of the edema. The imaging strategy significantly reduces the operating time due to its accuracy in locating the lymph vessels prior to surgery. With large field-of-view pre-operative imaging, the severity of lymphedema and the location of abnormal lymphatic vessels can be identified. Intra-operative ICG fluorescence lymphangiography provides focused and direct visualization of those vessels for surgical intervention. We believe both imaging methods are required to guarantee a successful treatment.
Note that the number of study subjects is relative small, but the promising results warrant further large-scale clinical trials or expanded clinical applications. In addition, it is very challenging to provide quantitative analysis of the imaging data due to local administration of the imaging agents. The clinical Tc-SC lymphoscintigraphy with anterior and posterior views showed dermal backflow from the left calve to the thigh and lymph node accumulation defect of the left side. The images were acquired at 6 h after tracer administration; b T 1 -weighted MR lymphangiography using three-dimensional (3D) gradient recalled echo (liver acquisition with volume acceleration (LAVA); left) and fast spin echo (FSE; middle) showed twisted, compensatory and discontinuous lymphatic channels of the left medial calf (arrows). T 1 -weighted with LAVA maximum intensity projection (MIP) reconstruction (right) showed multi-strip expansion and compensatory channels of the left medial calf (arrows). c-g 68 Ga-NEB PET lymphangiography acquired at 60 min after tracer administration showed slight dermal backflow of the left lower limb (C and G), lymph node accumulation defect at the affected side (c) including the left inguinal region (d), abnormal lymphatic channels at the left lower medial calve (f) and potential anastomosis pathway inside the medial calf (e). h Intraoperative ICG fluorescence lymphangiography provides real-time delineation of subdermal lymphatics inside the medial calf. i-k Personalized surgical plan and lymphatic venous anastomosis (LVA) were performed with an end-to-end lymphatic channel and suitably sized adjacent subcutaneous venule anastomosis. The length of the dilated channel dissected was further confirmed as the lymphatic vessel (i) with pathological HE staining (k) Tc-SC lymphoscintigraphy showed dermal backflow of the left lower limb, asymmetrical distribution of bilateral lymph nodes and accumulation defect on the left side. b-c MR lymphangiography showed dilated and discontinuous lymphatic channels of the left medial calf (arrows). d-h 68 Ga-NEB PET lymphangiography (60 min after tracer administration) represented a Bhoneycomb pattern^with dilated dermal lymphatics, discontinuous lymphatic channels and compensatory vessels and lymph lakes of the left lower limb (d), as well as different levels of dermal backflow (e and f) and lymph node accumulation defect on the affected left side (g and h). i-l A typical workflow of imaging-guided surgery planning using preoperative 68 Ga-NEB PET (i) and MRL (j) to discriminate the location of the lymphatic channels (k) for lymphatic venous anastomosis (l) effectiveness depends on careful technical performance and accurate image interpretation. Unfortunately, the conventional lymphoscintigraphy protocol is not standardized and varies according to the diagnostic service.
Conclusion
This study documented an effective imaging pattern to combine 68 Ga-NEB PET and MRL in patients with lower-limb lymphedema. This strategy has demonstrated significant advantage in the evaluation of lymphedema severity, staging and pathological location of lymph vessels to make individualized treatment plans. Dual 68 Ga-NEB PET/MR lymphangiography is thus recommended before the operation for lymphedema staging and therapy planning. , lymph node accumulation defect on the left inguinal region, and a length of dilated and tortuous lymphatic channels (e and f) of the affected medial calve. i Intra-operative ICG lymphangiography was unable to delineate lymphatic vessels due to limited penetration depth of optical Imaging and overall overgrowth of adipose tissue in stage III lymphedema
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